Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Mar. 31, 2020 $ (198,525) $ 399 $ 505,762 $ (703,164) $ (1,522)
Beginning balance (in shares) at Mar. 31, 2020   39,905      
Increase (Decrease) in Stockholders' Equity          
Net loss (35,459)     (35,459)  
Foreign currency translation adjustments, net of income taxes 666       666
Shares issued under employee stock purchase plan 1,335 $ 4 1,331    
Shares issued under employee stock purchase plan (in shares)   320      
Shares issued under employee incentive plans, net 0 $ 13 (13)    
Shares issued under employee stock incentive plans, net (in shares)   1,264      
Shares surrendered for employees' tax liability upon settlement of restricted stock units (236)   (236)    
Shares surrendered for employees' tax liability upon settlement of restricted stock units (in shares)   (44)      
Shares issued in connection with business acquisition 2,080 $ 3 2,077    
Shares issued in connection with business acquisition (in shares)   361      
Shares issued in connection with secondary equity offering, net 96,755 $ 151 96,604    
Shares issued in connection with secondary equity offering (in shares)   15,109      
Warrants issued related to long-term debt 11,515   11,515    
Deemed dividend on warrants 0        
Stock-based compensation 9,624   9,624    
Ending balance at Mar. 31, 2021 (112,245) $ 570 626,664 (738,623) (856)
Ending balance (in shares) at Mar. 31, 2021   56,915      
Increase (Decrease) in Stockholders' Equity          
Net loss (32,280)     (32,280)  
Foreign currency translation adjustments, net of income taxes (567)       (567)
Shares issued under employee stock purchase plan 1,762 $ 4 1,758    
Shares issued under employee stock purchase plan (in shares)   389      
Shares issued under employee incentive plans, net 0 $ 23 (23)    
Shares issued under employee stock incentive plans, net (in shares)   2,308      
Shares issued in connection with business acquisition 2,818 $ 8 2,810    
Shares issued in connection with business acquisition (in shares)   821      
Deemed dividend on warrants 0        
Stock-based compensation 13,829   13,829    
Ending balance at Mar. 31, 2022 $ (126,683) $ 605 645,038 (770,903) (1,423)
Ending balance (in shares) at Mar. 31, 2022 60,433 60,433      
Increase (Decrease) in Stockholders' Equity          
Net loss $ (37,943)     (37,943)  
Foreign currency translation adjustments, net of income taxes (158)       (158)
Shares issued under employee stock purchase plan 897 $ 6 891    
Shares issued under employee stock purchase plan (in shares)   600      
Shares issued under employee incentive plans, net 0 $ 21 (21)    
Shares issued under employee stock incentive plans, net (in shares)   2,180      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Shares issued in connection with business acquisition (in shares)   361      
Shares issued in connection with secondary equity offering, net 66,249 $ 300 65,949    
Shares issued in connection with secondary equity offering (in shares)   30,000      
Settlement of warrant down round provision 389   389    
Deemed dividend on warrants (389)   (389)    
Stock-based compensation 10,750   10,750    
Ending balance at Mar. 31, 2023 $ (86,888) $ 936 $ 722,603 $ (808,846) $ (1,581)
Ending balance (in shares) at Mar. 31, 2023 93,574 93,574